Abstract
The authors report two clinical trials concerning chemotherapy and immunotherapy combined in the treatment of primary and metastatic brain tumors. In the first study Bacillus Calmette-Guerin (BCG) and in the second levamisole (LMS) were utilized as immunostimulating agents. Chemotherapy was performed with BCNU and CCNU in association with surgery and/or radiotherapy. An immunological response was obtained but immunotherapy failed to demonstrate any significant effect on survival.
| Original language | English |
|---|---|
| Pages (from-to) | 19-24 |
| Number of pages | 6 |
| Journal | Journal of Neurosurgical Sciences |
| Volume | 29 |
| Issue number | 1 |
| Publication status | Published - 1985 |
Fingerprint
ASJC Scopus subject areas
- Clinical Neurology
Cite this
Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors. / Knerich, R.; Robustelli della Cuna, G.; Butti, G.; Pavesi, L.; Adinolfi, D.; Preti, P.; Locatelli, D.
In: Journal of Neurosurgical Sciences, Vol. 29, No. 1, 1985, p. 19-24.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors
AU - Knerich, R.
AU - Robustelli della Cuna, G.
AU - Butti, G.
AU - Pavesi, L.
AU - Adinolfi, D.
AU - Preti, P.
AU - Locatelli, D.
PY - 1985
Y1 - 1985
N2 - The authors report two clinical trials concerning chemotherapy and immunotherapy combined in the treatment of primary and metastatic brain tumors. In the first study Bacillus Calmette-Guerin (BCG) and in the second levamisole (LMS) were utilized as immunostimulating agents. Chemotherapy was performed with BCNU and CCNU in association with surgery and/or radiotherapy. An immunological response was obtained but immunotherapy failed to demonstrate any significant effect on survival.
AB - The authors report two clinical trials concerning chemotherapy and immunotherapy combined in the treatment of primary and metastatic brain tumors. In the first study Bacillus Calmette-Guerin (BCG) and in the second levamisole (LMS) were utilized as immunostimulating agents. Chemotherapy was performed with BCNU and CCNU in association with surgery and/or radiotherapy. An immunological response was obtained but immunotherapy failed to demonstrate any significant effect on survival.
UR - http://www.scopus.com/inward/record.url?scp=0022391133&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022391133&partnerID=8YFLogxK
M3 - Article
C2 - 3906050
AN - SCOPUS:0022391133
VL - 29
SP - 19
EP - 24
JO - Journal of Neurosurgical Sciences
JF - Journal of Neurosurgical Sciences
SN - 0026-4881
IS - 1
ER -